News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 5, 2024

Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2

Robert Gabbay, MD, PhD, delineates key differences between type 1 and type 2 diabetes, including autoimmune antibodies, insulin resistance, and insulin deficiency.

Episodes in this series

Video 1 - "Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2"

EP. 1 Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2

Video 2 - "Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3"

EP. 2 Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3

Video 3 - "Identifying Risk to Enable Early Detection of Type 1 Diabetes "

EP. 3 Identifying Risk to Enable Early Detection of Type 1 Diabetes

Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"

EP. 4 Challenges in Autoantibody Screening for Type 1 Diabetes

Video 5 - "Strategies for Preventing Progression of Early-Stage Type 1 Diabetes"

EP. 5 Strategies for Preventing Progression of Early-Stage Type 1 Diabetes

Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"

EP. 6 Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus

Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"

EP. 7 Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

spleen and liver | Image credit: RFBSIP - stock.adobe.com

Selinexor Shows Modest Spleen Response in JAK Inhibitor–Refractory MF

BySkylar Jeremias

August 31st 2026

Brain and lungs. | Image credit: @magicmine_AdobeStock.jpeg

CPFE: Why Spirometry Alone Misses Emphysema in Fibrotic ILD

BySabrina McCrear

August 31st 2026

Expert featured in this series.

New Registry Data on MAC Pulmonary Disease Outcomes

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

Expert featured in this series.

Top Unmet Needs in MAC Pulmonary Disease Management

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

DLBCL | Image: Marshall Kadin/ASH Image Bank

20 Years of ADC Trials in Lymphoma Leave Many Questions Unanswered, Authors Say

August 30th 2026

Trending on AJMC

Multiagonists Outpace Older GLP-1 Drugs for Weight Loss

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

Midsized Biotechs Strike MFN Drug Pricing Deals

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes